Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
North Carolina Biotechnology Center
AddedFeb 16, 2024
UpdatedJul 16, 2026
North Carolina Biotechnology Center

North Carolina Biotechnology Center

North Carolina Biotechnology Center: A pioneering non-profit, merging academia and business to support biotech research and policy.

HQ
Triangle (historical), NC, US
Founded
1984
Overview
Compare
Fundraising
Employees
Website

The North Carolina Biotechnology Center (NCBiotech) is a non-profit, public-private partnership organization founded in 1984 by the North Carolina General Assembly. Located in Research Triangle Park, it was the first state-sponsored biotechnology initiative in the United States. NCBiotech's core mission is to drive long-term economic and societal benefits for North Carolina by fostering the growth of the biotechnology sector. The organization offers a range of services including funding opportunities, networking events, and training programs aimed at supporting biotech research, policy development, and industry growth.

Notable figures affiliated with NCBiotech include leaders from both academic institutions and private industry, reflecting its collaborative approach. The organization has received support from various investors and stakeholders committed to advancing biotechnology. Key achievements include significant contributions to the state's economic development through job creation and industry innovation. Overall, NCBiotech has had a profound impact on positioning North Carolina as a leader in the life sciences sector, facilitating advancements in research and commercial applications.

North Carolina Biotechnology Center - Quick Facts

When was North Carolina Biotechnology Center founded?

North Carolina Biotechnology Center was founded in 1984.

Where is North Carolina Biotechnology Center's headquarters located?

North Carolina Biotechnology Center's headquarters is located in Triangle (historical), NC, US.

When was North Carolina Biotechnology Center's last funding round?

North Carolina Biotechnology Center's most recent funding round was for $25M (USD) in September 2022.

How much has North Carolina Biotechnology Center raised to-date?

As of Sep 2, 2022, North Carolina Biotechnology Center has raised a total of $30.4M (USD).

How many employees does North Carolina Biotechnology Center have?

North Carolina Biotechnology Center has 116 employees as of Feb 4, 2024.

North Carolina Biotechnology Center - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
  • Government
  • Non-Profit
Main Product
  • Biotech Research
Tags
  • Consulting
NAICS
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 611000Educational Services
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8200Educational Services
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 7371Computer Programming Services
  • 7372Prepackaged Software